1. Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
- Author
-
Robert W. Cross, Brian M. Sullivan, Saori Sakabe, Lucy E Horton, John S. Schieffelin, Mambu Momoh, Robert F. Garry, Emily J Engel, Thomas W. Geisbert, Jessica N. Hartnett, Donald S. Grant, Augustine Goba, and John Demby Sandi
- Subjects
Male ,Epidemiology ,vector-borne infections ,lcsh:Medicine ,protein C ,chemistry.chemical_compound ,0302 clinical medicine ,Platelet ,030212 general & internal medicine ,Child ,platelet ,Endothelial protein C receptor ,Middle Aged ,Infectious Diseases ,Child, Preschool ,Plasminogen activator inhibitor-1 ,Female ,fibrinolysis ,hemorrhagic fever ,medicine.drug ,Lassa fever ,Adult ,Blood Platelets ,Microbiology (medical) ,medicine.medical_specialty ,Adolescent ,030231 tropical medicine ,Thrombomodulin ,Sierra Leone ,Sierra leone ,lcsh:Infectious and parasitic diseases ,Young Adult ,03 medical and health sciences ,Tissue factor ,Internal medicine ,medicine ,Humans ,viruses ,lcsh:RC109-216 ,Endothelium ,coagulation ,Blood Coagulation ,Aged ,business.industry ,Research ,lcsh:R ,Infant ,zoonoses ,Endocrinology ,chemistry ,Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever ,Hemostasis ,hemostasis ,business ,Protein C - Abstract
Lassa fever (LF) causes multisystem disease and has a fatality rate
- Published
- 2020